eli lilly glp-1 receptor agonist medications Shortages improve for Lilly's weight loss drugs, bumping sales forecast by $3bn Eli Lilly's Oral GLP-1 Therapy

The Reality: DSIP Is Not an Approved Treatment DSIP is: Not FDA approved Not prescribed in addiction treatment programs Not included in clinical guidelines for opioid use disorder Even though it sounds promising on the surface, theres no strong evidence showing that DSIP can: Reduce cravings Prevent relapse Replace evidence-based treatments Its being discussed far more in online communities and experimental spaces than in real medical settings

J Biomed Nanotechnol 12:20012014

She has also written for a variety of publications including Business Insider, Glamour, Bustle, Metro, HuffPost UK, gal-dem and more

Am J Epidemiol (2007) 166(5):495505